These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 29793239)

  • 1. Personalized medicine: how much can we afford? A bioethics perspective.
    Lunshof J
    Per Med; 2005 Mar; 2(1):43-47. PubMed ID: 29793239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Personalized medicine policy challenges: measuring clinical utility at point of care.
    van Rooij T; Wilson DM; Marsh S
    Expert Rev Pharmacoecon Outcomes Res; 2012 Jun; 12(3):289-95. PubMed ID: 22812553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Person Centered Care and Personalized Medicine: Irreconcilable Opposites or Potential Companions?
    El-Alti L; Sandman L; Munthe C
    Health Care Anal; 2019 Mar; 27(1):45-59. PubMed ID: 28936750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bringing personalized medicine to the community through public engagement.
    Etchegary H; Wilson B
    Per Med; 2013 Sep; 10(7):647-659. PubMed ID: 29768762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacogenomics and public health: implementing 'populationalized' medicine.
    Mette L; Mitropoulos K; Vozikis A; Patrinos GP
    Pharmacogenomics; 2012 May; 13(7):803-13. PubMed ID: 22594512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A research roadmap for complementary and alternative medicine - what we need to know by 2020.
    Fischer F; Lewith G; Witt CM; Linde K; von Ammon K; Cardini F; Falkenberg T; Fønnebø V; Johannessen H; Reiter B; Uehleke B; Weidenhammer W; Brinkhaus B
    Forsch Komplementmed; 2014; 21(2):e1-16. PubMed ID: 24851850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Personalized medicine and the role of health economics and outcomes research: issues, applications, emerging trends, and future research.
    O'Donnell JC
    Value Health; 2013; 16(6 Suppl):S1-3. PubMed ID: 24034305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conference Scene: Is personalized medicine ready for prime time?
    Kraus WE; Haga SB; McLeod HL; Staples J; Ginsburg GS
    Per Med; 2012 Jul; 9(5):475-478. PubMed ID: 29768766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Considering virtue: public health and clinical ethics.
    Meagher KM
    J Eval Clin Pract; 2011 Oct; 17(5):888-93. PubMed ID: 21834841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The future of genomic testing in primary care: the changing face of personalized medicine.
    Bartlett G; Rahimzadeh V; Longo C; Orlando LA; Dawes M; Lachaine J; Bochud M; Paccaud F; Bergman H; Crimi L; Issa AM
    Per Med; 2014 Jul; 11(5):477-486. PubMed ID: 29758776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Group-based and personalized care in an age of genomic and evidence-based medicine: a reappraisal.
    Maglo KN
    Perspect Biol Med; 2012; 55(1):137-54. PubMed ID: 22643722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical and health economic challenges of personalized medicine].
    Brüggenjürgen B; Kornbluth L; Ferrara JV; Willich SN
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2012 May; 55(5):710-4. PubMed ID: 22526860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation, reimbursement, and the long road of implementation of personalized medicine--a perspective from the United States.
    Frueh FW
    Value Health; 2013; 16(6 Suppl):S27-31. PubMed ID: 24034309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wanted: a new ethics field for health policy analysis.
    Kenny N; Giacomini M
    Health Care Anal; 2005 Dec; 13(4):247-60. PubMed ID: 16435463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Japan as the front-runner of super-aged societies: Perspectives from medicine and medical care in Japan.
    Arai H; Ouchi Y; Toba K; Endo T; Shimokado K; Tsubota K; Matsuo S; Mori H; Yumura W; Yokode M; Rakugi H; Ohshima S
    Geriatr Gerontol Int; 2015 Jun; 15(6):673-87. PubMed ID: 25656311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Why bioethics today?].
    Figueroa G
    Rev Med Chil; 1995 Jun; 123(6):777-84. PubMed ID: 8525234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genotype-guided use of oral antithrombotic therapy: a pharmacoeconomic perspective.
    Sweezy T; Mousa SA
    Per Med; 2014 Mar; 11(2):223-235. PubMed ID: 29751379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Economic Perspectives on Personalized Health Care and Prevention.
    Phillips KA; Sakowski JA; Liang SY; Ponce NA
    Forum Health Econ Policy; 2013 Sep; 16(2):S23-S52. PubMed ID: 31419875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A bioethics for all seasons.
    Chan S
    J Med Ethics; 2015 Jan; 41(1):17-21. PubMed ID: 25516926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cooperation, Trust, and Antagonism: How Public Goods Are Promoted.
    Parks CD; Joireman J; Van Lange PA
    Psychol Sci Public Interest; 2013 Dec; 14(3):119-65. PubMed ID: 26171620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.